Four Low-Risk Morningstar Medalists


When we assign Morningstar Analyst Ratings, we are thinking about a fund’s risk-adjusted prospects. In short, are you getting paid for the risk you're taking? Or, will you be able to handle the downside in order to get through to the upside?

If you look at the Morningstar Risk & Rating Statistics on our Ratings & Risk tab, you see a fund's Morningstar Risk rating. It tells you if a fund's volatility is Low, Below Average, Average, Above Average, or High for its category.

We have a number behind those words, so I decided to highlight some Morningstar Medalists that have been at the very low end of volatility for their categories. Keep in mind that it's a relative-to-category measure--even a very low-risk emerging-markets fund is much more volatile than your typical intermediate-term bond fund.

American Century Equity Income (TWEIX) has produced nice returns, but it's the risk-adjusted returns that really look attractive. The fund tones down equity risk by holding a sleeve of convertible bonds in the 15% to 25% range. Lead manager Phil Davidson is a cautious investor who tries to tamp down volatility. Thus, this fund shines in down years by losing much less than the competition. However, when stocks rally as in 2013, you expect it to lag. Sure enough, it's near the cellar for the year to date.

Akre Focus (AKREX) typically has around 15% or so in cash and sometimes more. That helps to tone down volatility but so does manager Chuck Akre's emphasis on quality, which gives the fund a mix of value and growth char­acteristics. Akre wants strong busi­ness models that can produce outstanding returns on capital, and he wants shareholder-oriented managers to run them. This leads him to the steadier side of growth, investing with names like MasterCard (MA) and Moody's (MCO). It's a good thing, too, because Akre bets big on his favorites, with nearly 10% in MasterCard.

ASTON/Montag & Caldwell Growth (MCGFX) is another lower-risk growth fund. Manager Ron Cana­karis and team look for stable growers trading at a modest price. This leads them to large-cap, well-known names like Abbott Laboratories (ABT), Coca-Cola (KO), and Google (GOOG). Canakaris is 69 years old, but we still feel good about the fund's prospects. I visited the firm in Atlanta and was pleased to see that it is in good shape, with a number of managers and analysts behind Canakaris who can take up the slack if he should retire. I'm also pleased that the firm is now employee-owned and Canakaris will sell back his shares when he retires.

Like American Century Equity Income, First Eagle U.S. Value(FEVAX) has been a champ in down markets and a laggard in up markets. However, its long-term returns are quite good, so it would seem that it has done a fine job rewarding shareholders. The fund plays defense in quite a few ways. It holds a big cash stake, but that's only one part of the story.

True to founder Jean-Marie Eveillard's philosophy, Matt McLennan and Abhay Deshpande are focused on capital preservation. They look for companies with healthy balance sheets and profit margins but whose shares are trading at a big discount to their estimates of intrinsic value. They like some gold or potash producers for their defensive characteristics. The fund lost 14 percentage points less than the S&P 500 Index did in 2008 and 4 fewer in 2011, but it is lagging by 12 percentage points this year. Generally, the best time to buy a fund like this is after a couple of years near the back of the pack, as that could mean risk is rising. No doubt, this fund's defenses will be valued yet again.

Knicks Vs. Lakers
I got some questions about why I didn't include the Knicks or Lakers in my last poll. So, I thought I'd correct for that today.

For a list of the open-end funds we cover, click here.
For a list of the closed-end funds we cover, click here.
For a list of the exchange-traded funds we cover, click here.
For information on the Morningstar Analyst Ratings, click here.

Russel Kinnel does not own shares in any of the securities mentioned above.

View Comments (0)